Fresenius Medical Care AG (NYSE:FMS) Sees Significant Decrease in Short Interest

Fresenius Medical Care AG (NYSE:FMS) was the target of a large drop in short interest in February. As of February 15th, there was short interest totalling 607,700 shares, a drop of 24.5% from the January 31st total of 804,400 shares. Based on an average trading volume of 253,200 shares, the short-interest ratio is presently 2.4 days.

Fresenius Medical Care Stock Performance

Shares of NYSE FMS opened at $23.49 on Tuesday. Fresenius Medical Care has a 12 month low of $17.93 and a 12 month high of $25.25. The company has a market cap of $13.78 billion, a P/E ratio of 19.41, a P/E/G ratio of 0.76 and a beta of 0.93. The business’s 50 day moving average is $23.47 and its two-hundred day moving average is $21.92. The company has a quick ratio of 1.02, a current ratio of 1.37 and a debt-to-equity ratio of 0.42.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the company. Truist Financial upped their target price on Fresenius Medical Care from $23.00 to $25.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. Berenberg Bank started coverage on shares of Fresenius Medical Care in a report on Wednesday, November 6th. They set a “buy” rating and a $25.60 price objective for the company. StockNews.com upgraded shares of Fresenius Medical Care from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, February 5th. Finally, Bank of America raised shares of Fresenius Medical Care from an “underperform” rating to a “neutral” rating in a research report on Monday, December 2nd.

Hedge Funds Weigh In On Fresenius Medical Care

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Smartleaf Asset Management LLC grew its position in Fresenius Medical Care by 192.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company’s stock worth $28,000 after purchasing an additional 806 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in Fresenius Medical Care during the third quarter worth about $38,000. Russell Investments Group Ltd. increased its stake in Fresenius Medical Care by 234.1% during the fourth quarter. Russell Investments Group Ltd. now owns 3,151 shares of the company’s stock valued at $71,000 after acquiring an additional 2,208 shares during the period. Jones Financial Companies Lllp raised its holdings in Fresenius Medical Care by 80.5% in the 4th quarter. Jones Financial Companies Lllp now owns 4,510 shares of the company’s stock valued at $102,000 after acquiring an additional 2,012 shares in the last quarter. Finally, Venturi Wealth Management LLC raised its holdings in Fresenius Medical Care by 1,045.8% in the 3rd quarter. Venturi Wealth Management LLC now owns 5,259 shares of the company’s stock valued at $112,000 after acquiring an additional 4,800 shares in the last quarter. Institutional investors own 8.37% of the company’s stock.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.